financetom
Business
financetom
/
Business
/
Emerald Holding Q2 Loss Narrows, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emerald Holding Q2 Loss Narrows, Revenue Rises
Aug 4, 2025 4:32 AM

06:59 AM EDT, 08/04/2025 (MT Newswires) -- Emerald Holding ( EEX ) reported Q2 net loss Monday of $0.01 per diluted share, narrowing from $0.03 per share a year earlier.

Analysts surveyed by FactSet expected $0.00.

Revenue for the quarter ended June 30 was $105.5 million, up from $86.0 million a year earlier.

Analysts surveyed by FactSet expected $100.2 million.

The company added that it is reaffirming its previously stated fiscal 2025 guidance of $450 million to $460 million of revenue.

Analysts surveyed by FactSet expect $453.5 million.

Emerald shares were up 3.7% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is G-III Apparel Stock Shooting Higher Today?
Why Is G-III Apparel Stock Shooting Higher Today?
Mar 13, 2025
G-III Apparel Group Ltd ( GIII ) shares are trading higher in premarket on Thursday after the fourth-quarter FY25 earnings report. The company reported fourth-quarter sales growth of 9.8% year-on-year to $839.535 million, beating the analyst consensus estimate of $807.590 million. The gross profit rose 17.6% Y/Y to $331.6 million, with the margin expanding 270 basis points to 39.5%. Selling,...
Tempest Therapeutics Says Familial Adenomatous Polyposis Trial Gets US FDA 'Study May Proceed' Notice
Tempest Therapeutics Says Familial Adenomatous Polyposis Trial Gets US FDA 'Study May Proceed' Notice
Mar 13, 2025
08:41 AM EDT, 03/13/2025 (MT Newswires) -- Tempest Therapeutics ( TPST ) said Thursday that the mid-stage clinical trial of TPST-1495 for the treatment of familial adenomatous polyposis has received a study may proceed letter from the US Food and Drug Administration. The clinical-stage company said the Cancer Prevention Clinical Trials Network will run the mid-stage study, which will start...
Wang & Lee Group Acquires SolarHK to Support Crypto Mining Projects in Hong Kong, Australia
Wang & Lee Group Acquires SolarHK to Support Crypto Mining Projects in Hong Kong, Australia
Mar 13, 2025
08:39 AM EDT, 03/13/2025 (MT Newswires) -- Wang & Lee Group ( WLGS ) said Wednesday it signed a deal to buy SolarHK for 15 million Hong Kong dollars ($1.9 million), through the issuance of a convertible note. The company said the deal is intended to support upcoming clean energy initiatives, including a $100 million solar and battery-powered crypto mining...
Egypt in talks with Excelerate Energy for floating gas unit, ministry says
Egypt in talks with Excelerate Energy for floating gas unit, ministry says
Mar 13, 2025
CAIRO, March 13 (Reuters) - Egypt is in talks with Excelerate Energy ( EE ) for a floating storage and regasification unit (FSRU) to help ensure steady natural gas supplies for the Egyptian domestic market, the petroleum ministry said in a statement on Thursday. Steven Kobos, CEO of Excelerate Energy ( EE ), expressed his company's readiness to supply the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved